Stockreport

Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst ... [Yahoo! Finance]

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF Research and Development Expenses: $14.6 million in Q3 2024, down from $18.2 million in Q3 2023. General and Administrative Expenses: $8.4 million in Q3 2024, down fr [Read more]